Articles Tagged With:
Vaccinate Children Against MIS-C, a Serious Post-COVID Syndrome
COVID-19 vaccination can greatly reduce multisystem inflammatory syndrome in children, a rare but serious complication associated with SARS-CoV-2 infection, researchers are finding.
IPs Rally Forward at APIC 2022
Infection preventionists experienced exhaustion and burnout during the COVID-19 pandemic. However, at the 2022 conference of the Association for Professionals in Infection Control and Epidemiology, they were urged to stay connected and strong.
Differentiating and Managing Pediatric Shock
Early recognition and management of pediatric shock is critical for acute care providers. The authors review the subtle presentations, different approaches, and management strategies to effectively manage the different types of pediatric shock.
Evaluation of Trauma in Older Adults
The healthcare system is treating more older adults with unique physiologic and anatomic considerations that must be taken into account in trauma resuscitation to maximize each patient’s outcome.
Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373)
Novavax is authorized to be administered to patients age 18 years and older for active immunization to prevent COVID-19 caused by SARS-CoV-2.
Rivaroxaban Monotherapy for Atrial Fibrillation in Coronary Artery Disease Patients
For patients with atrial fibrillation and stable coronary artery disease, rivaroxaban monotherapy was superior to dual therapy for preventing thrombotic and bleeding events and was associated with a lower mortality rate.
The Value of Stress Testing in Patients with Known Coronary Artery Disease
A comparison of adenosine stress single-photon emission CT, PET, and MRI in stable patients with known coronary artery disease (CAD) showed PET to be more sensitive for detecting invasive fractional flow reserve-identified ischemic lesions. However, the sensitivity was disappointing. Patients with known CAD and new symptoms should be referred directly to invasive coronary angiography.
Inflammatory Foods Could Accelerate Brain Aging
In the Framingham Offspring cohort of subjects, those with a higher index of inflammatory foods recorded smaller brain volume, less grey matter.
COVID-19 Rebound
Symptomatic and virologic recrudescence after treatment of patients with COVID-19 with Paxlovid occurs in a tiny percentage of patients and generally is mild and self-limited.
COVID-19: Duration of Shedding of Transmissible Virus
Patients with COVID-19 were found, by culture, to shed replication-competent virus after an initial PCR test for median durations of four to five days.